Long non-coding RNA TUG1 regulates multiple glycolytic enzymes in hepatocellular carcinoma cells by sponging microRNA-122-5p.

Hepatocellular carcinoma (HCC) remains the third leading cause of cancer-related deaths worldwide; however, its therapeutic options are limited. Understanding the molecular mechanisms of HCC could provide insight into new therapies. Emerging studies indicate the important role of long-noncoding RNAs (lncRNAs) in the pathogenesis of HCC. The expression of the well-studied lncRNA taurine upregulated gene 1 ( TUG1) is upregulated in HCC tissues, but its transcriptomic effects in HCC cells remain unexplored. We established TUG1-knockdown and control HCC cells for RNA-seq experiments. KEGG analysis revealed glycolysis as the top enriched pathway upon TUG1 silencing. Accordingly, TUG1-depleted HCC cells showed impairments in glucose uptake, ATP synthesis, and lactate production. Clinical HCC tissue data revealed positive gene expression correlations between TUG1 and several glycolysis-related genes. To identify a molecular function of TUG1 in glycolysis, we explored the competing endogenous model and used bioinformatic tools to find the five microRNAs (miRNAs) that had the most binding sites for TUG1. Among these miRNAs, miR-122-5p exhibited an inverse correlation in gene expression with most TUG1-regulated glycolysis genes, including PKM, ALDOA, ENO2, and PFKM. Dual-luciferase assays demonstrated the direct interaction between TUG1 and miR-122-5p and between miR-122-5p and the 3' untranslated regions of both PKM and ALDOA. We further showed that inhibition of miR-122-5p alleviated the suppression of glycolysis induced by TUG1 depletion. Together, our RNA-seq analysis of TUG1-depleted HCC cells, combined with clinical data, reveals a critical role of TUG1 in regulating glycolysis and provides new insight into its oncogenic function in HCC.